We carry out research projects in close collaboration with authorities and national and international companies linked to the aquaculture sector with the objective to elucidate and prevent pathologies caused by bacteria and virus in different cultivated fish species like eels, sea bass, sea bream, turbot, sole, tilapia or trout as well as in crustacean (shrimp) and mollusks (oyster).
Our works include:
- Detection and typing of bacterial or viral pathogens, classical or emerging ones, some of them with zoonotic potential. Some of them are Vv, V. anguillarum, V. harveyi, Photobacterium damselae, Edwarsiella tarda, Lactococcus garvieae, Yersinia ruckeri, betanodavirus, Infectious Pancreatic Necrosis (IPN) virus…
- Infectious diseases diagnosis.
- Antibacterial therapy, minimizing the use of antibiotics.
- Prophylaxis; optimization of immunostimulation strategies and diseases prevention, development of new nutritional alternatives respectful with the environment as well as new vaccines and administration procedures adapted to every phase of the productive cycle of the animal.
- Epizootiology of diseases; ways of transmission and search of reservoirs or new susceptible hosts.
- Microbiological quality control of waters.
Our group has developed several methods for fish pathogen’s detection that are fast and sensitive. Among them:
- Isolation of Vv from environmental and clinical samples
- PCR multiplex for Vv fish-virulent strains
- Simple PCR for zoonotic
- Vv strainsGenetic/serologic protocol for V.harveyi fish-virulent strains
- Phenotypic/serologic protocol for Yersinia ruckeri biotype 2
- qRT-PCR for Betanodavirus

Besides, we have developed immunization protocols as well as techniques to assess the efficacy of specific (i.e. vaccines) and non-specific immunostimulants (functional diets). In fact, we patented a vaccine for Vv awarded with Jacumar Award. This vaccine protects against fish vibriosis because induces antibody production in skin fish and serum (Fouz et al., 2001 & Esteve-Gassent et al., 2003)
Our group collaborates with different groups and companies/research institutes that reflects our mission and commitment in translating basic research into clinical applications.
